Search
Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021: informe d'avaluació de resultats
(2022-02)
Minority diseases pose a major challenge to the health system, as they often have a genetic origin, can affect many organs, be serious, pose a vital threat, or be chronically debilitating. Their diagnosis is difficult, ...
Formoterol/bromur de glicopirroni/budesonida per al tractament de manteniment de la malaltia pulmonar obstructiva crònica
(2022-02-01)
Formoterol / glycopyrronium bromide / budesonide (FOR / GLIC / BUD) is a fixed-dose combination (CDF) of a long-acting beta-2-adrenergic agonist (LABA), a long-acting muscarinic antagonist (LAMA). and an inhaled corticosteroid ...
Dupilumab per al tractament de l’asma greu no controlada
(2022-01-01)
Uncontrolled severe asthma (AGNC) is defined as the disease that persists in poorly controlled despite receiving treatment with a combination of a high-dose inhaled corticosteroid (CI) and a long-acting beta-2-adrenergic ...
Impacte de la COVID-19 a les urgències: Catalunya 2020 (46/2022)
(2022-03)
This new report is a continuation of issue 44, which presents a first analysis of urgent activity in Catalonia for the year 2020 and some of the implications of the emergence of COVID-19 in this area